Cypress Pharmaceuticals Private Limited

Pharmaceutical company that formulates, distributes, and markets drugs, cosmetics, and medicinal preparations.

2017 | Thane, Maharashtra (India) | Active
Last Updated:

Cypress Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.38 Cr
  • Paid Up Capital ₹ 1.30 Cr
  • Company Age 8 Year, 2 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth -83.81%
  • Profit Growth -19.95%
  • Ebitda -20.18%
  • Net Worth -118.92%
  • Total Assets -51.43%

About Cypress Pharmaceuticals

Cypress Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2017 (Eight years and two months 20 days old ). Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.38 Cr and a paid-up capital of Rs 1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.

Lav Kumar and Rakesh Ranjan serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999MH2017PTC292146

  • Company No.

    292146

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    07 Mar 2017

  • Date of AGM

    31 Dec 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Healthcare
Pharma
Company report

Cypress Pharmaceuticals Private Limited

Explore comprehensive data for Cypress Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Cypress Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Lav Kumar Country flag representing In Director Current
Rakesh Ranjan Country flag representing In Director 26-Aug-2019Current

Financial Performance of Cypress Pharmaceuticals.

Cypress Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 83.81% decrease. The company also saw a substantial fall in profitability, with a 19.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 118.92%.

Cypress Pharmaceuticals revenue growth over time
Cypress Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-83.81%
Revenue from Operations
-83.81%
Total Assets
-51.43%
Profit or Loss
-19.95%
Net Worth
-118.92%
EBITDA
-20.18%

What is the Ownership and Shareholding Structure of Cypress Pharmaceuticals?

In 2020, Cypress Pharmaceuticals had a promoter holding of 7.52% and a public holding of 92.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Cypress Pharmaceuticals?

Unlock and access historical data on people associated with Cypress Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Cypress Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cypress Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cypress Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cypress Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Cypress Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.

  • Balance Sheet

    Cypress Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai.

  • Director Appointment

    Rakesh Kumar Ranjan was appointed as a Director was appointed as a Director on 26 Aug 2019 & has been associated with this company since 5 years 9 months .

  • Company Incorporation

    Cypress Pharmaceuticals Private Limited was registered on 07 Mar 2017 with Roc Mumbai & aged 8 years 2 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Cypress Pharmaceuticals Private Limited?

    Cypress Pharmaceuticals Private Limited was incorporated on 07 Mar 2017.

  • What is authorized share capital and paid-up capital of Cypress Pharmaceuticals Private Limited?

    The authorized share capital of Cypress Pharmaceuticals Private Limited is ₹ 1.38 Cr and paid-up capital is ₹ 1.30 Cr.

  • Who are the current board members & directors of Cypress Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Cypress Pharmaceuticals Private Limited.

    • Lav Kumar
    • Rakesh Kumar Ranjan

  • What is the registered address of Cypress Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cypress Pharmaceuticals Private Limited is Flat No. F/604 Elite Building Kalyan Shil Road, Nilje India, Mumbai, Maharashtra, 421203.

  • What is the corporate identification number (CIN) and company number of Cypress Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Cypress Pharmaceuticals Private Limited is U74999MH2017PTC292146 and the company number is 292146 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Cypress Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Cypress Pharmaceuticals Private Limited has fallen by -83.81%.

  • What change has been observed in the net worth of Cypress Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Cypress Pharmaceuticals Private Limited has experienced an downturn of -118.92%.

  • When was the last Balance Sheet of Cypress Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Cypress Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors